Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

Micro-Tech (Nanjing) Co.,Ltd (688029.SS)

Compare
67.29
-2.91
(-4.15%)
At close: April 3 at 3:00:03 PM GMT+8
Loading Chart for 688029.SS
  • Previous Close 70.20
  • Open 69.68
  • Bid 67.29 x --
  • Ask 67.30 x --
  • Day's Range 67.15 - 70.65
  • 52 Week Range 55.38 - 89.92
  • Volume 3,756,833
  • Avg. Volume 1,885,167
  • Market Cap (intraday) 12.64B
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) 22.89
  • EPS (TTM) 2.94
  • Earnings Date --
  • Forward Dividend & Yield 1.50 (2.23%)
  • Ex-Dividend Date Oct 11, 2024
  • 1y Target Est --

Micro-Tech (Nanjing) Co.,Ltd researches, develops, manufactures, and sells minimally invasive medical devices to hospitals and clinics worldwide. It offers micro-tech endoscopy gastroenterology devices, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, retrieval devices, and accessories. The company also offers OEM/ODM services. Micro-Tech (Nanjing) Co.,Ltd was founded in 1999 and is based in Nanjing, China.

www.micro-tech.com.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688029.SS

View More

Performance Overview: 688029.SS

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688029.SS
0.44%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

688029.SS
0.62%
SSE Composite Index (000001.SS)
8.89%

3-Year Return

688029.SS
22.33%
SSE Composite Index (000001.SS)
1.81%

5-Year Return

688029.SS
37.78%
SSE Composite Index (000001.SS)
20.91%

Compare To: 688029.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688029.SS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    12.64B

  • Enterprise Value

    11.17B

  • Trailing P/E

    22.89

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.70

  • Price/Book (mrq)

    3.39

  • Enterprise Value/Revenue

    4.17

  • Enterprise Value/EBITDA

    17.04

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.98%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    14.77%

  • Revenue (ttm)

    2.76B

  • Net Income Avi to Common (ttm)

    551.67M

  • Diluted EPS (ttm)

    2.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.52B

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 688029.SS

View More

Company Insights: 688029.SS

Research Reports: 688029.SS

View More

People Also Watch